661. Enhanced In Vivo Oncolysis Using a Chimeric Adenovirus Serotype 5 Vector with Serotype 3 Tropism

661. Enhanced In Vivo Oncolysis Using a Chimeric Adenovirus Serotype 5 Vector with Serotype 3 Tropism

!"!"   3     C        "2          3          3  ...

163KB Sizes 0 Downloads 86 Views

!"!"   3     C        "2       

  3          3        ? D"?!  @'D       3'   0  3

    8=     -: 

        /      ? D   @'D"



           

        ' &               3       ? D @'D             -?  $@" 6   $@"&/ 0      2      

            ? D   @'D 



           ? D"?!            @'D         3    ? D"?!   @'D               2                "             

           

658. Differential T ransduction of Prostate T umor Cells Transduction Tumor by Adenovirus T ype 5 V ectors Pseudotyped with Fiber Type Vectors Proteins from Subgroup B, C, and D Viruses Dan J. Von Seggern,1 Catherine Hsu,1 Lance D. Gritton.1 1 Immunology, The Scripps Research Institute, La Jolla, CA, United States. #                                           - "  /                         

      "                                        

         

            #    &9 '    

          -' &/   

    

             '           

                              

     ' &      3

 "       

 '@ -3     '    @   / @            '                  

   "'@     3  '@′     3   ' &    

                           ' &                           @            '@        3

                

  

                  '@ 3  0      

  '                             

      4    ' =   ' =;          

3 

         ' &        >2." 

 2         0     1               '           !    .          '   (   2 -' = ' 8B/  -' &/   $ -' 85 ' =;/    

         

       !"= $486&   D!           

                 -  ' &/            3  .    

1

     ' = ' =;   ' 85           

  ' &      ' 8B   

                  @                        2   $       



659. Genetic Manipulations of Adenovirus T ype 5 Fiber Type Decreasing Binding to the Coxsackie and Adenovirus Receptor Result in Liver T ropism Attenuation Tropism 1,2

1

Emmanuelle Vigne, Jean-Francois Dedieu, Martine LattaMahieu,1 Michel Perricaudet,2 Patrice Yeh.1,2 1 Gencell, Aventis Pharma, Vitry-sur-Seine, France; 2UMR1582, CNRS/IGR/Aventis, Villlejuif, France.         

                   1        



                               & -' &/         

      "                     3     '    @    -'@/      

          

             -   2(8/                 

S216

     ' = -   $2B/                    

    89"                 G

 '@        

        '@"      #        2(8           

                     

 ' &   "  

      "                        -'@         /     E   2(8   $2B          

                       3           $*' 





           ?                 

      

    

  2(8"   $2B

             

                 "'@" 

    ' =                 '@     ' &"

          

660. Comparison of Different Viral Promoters for Adenoviral - Mediated Sensitization of Human T umor Tumor Cells to CPT -1 1 CPT-1 -11 Monika Wierdl,1 Christopher L. Morton,1 Rebecca A. Burger,1 Ruchi Khanna,1 Mary K. Danks,1 Philip M. Potter.1 1 Molecular Pharmacology, St. Jude Children′s Research Hospital, Memphis, TN, United States.     ! "88    

           

  (*"=:   '                  &H        

 ! "88      !  %                            

              0     

   3    ->/         

3

                3              ! "88    >        899        ! "88                

          

 

 G "     -.$>! /      

 >   ! "88 0   

         3  

 >          @(. -' @(. >/   #. -' #. >/    .       

     ,5=         G

  !@         3

 6 3 8989       

 ?                            

 

>    

! "88  C             

   > 3      ! "88           

  ' #. >                     >      

   G  ! "88           

    @(.   #.     C                                       3     >     #.          >3

      ' #. >   

                     ( 

*C  ';B,9,';5;B=  ' D 

(  ' 

    

661. Enhanced In Vivo Oncolysis Using a Chimeric Adenovirus Serotype 5 V ector with Serotype 3 T ropism Vector Tropism Yosuke Kawakami,1,2 Jerry L. Blackwell,1,2 Hui Li,1,2 Victor Krasnykh,1,2 David T. Curiel.1,2 1 Division of Human Gene Therapy, Departments of Medicine, Pathology, and Surgery, University of Alabama at Birmingham, Birmingham, AL, United States; 2The Gene Therapy Center, University of Alabama at Birmingham, Birmingham, AL, United States. '      & -' &/     

                            "                    C              

  

      ' & 

           ' &    3    "      -'@/ )                   



Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy

!"!"  ' &        '@           

3 '@                      

                     3             ' &    

 ' &%=    

   

       =                       '@"           0        

        ' &%=                         

           

  ' &                      1

             

      

          

        

     #                                  "  

                 

    

         ' &%=    

            

    0    



   1        

      -(C*/          ' &%=     ' &    3                  '   (C*   

         ' &%=        ' &          

                (C*       

      ' &%=   ' &   

   ;          

                 ' &%=       ' &  (C*   0   3 

               ' &%=      

   

           

  E    '      E 

 (C*     

    ' &%=   ' &           *    8,         ' &%=" 

     

     ,   89     

  ' &" 

  

         

   ' &%=      ;:6 = 

 =;        ' &   =B9  =        

 '             (C*      

                                 ' &  

662. Coxsackievirus-Adenovirus Receptor Genetically Fused to Anti Human CD40 scFv Enhances Adenoviral Transduction of Dendritic Cells Alexander V. Pereboev,1,2 Clement K. Asiedu,4 Yosuke Kawakami,1,2 Sai Sai Dong,4 Jerry L. Blackwell,1,2 Elena A. Kashentseva,1,2 Pierre L. Triozzi,2,3 Wayne A. Aldrich,2,3 David T. Curiel,1,2 Judith M. Thomas,2,4 Igor P. Dmitriev.1,2 1 Division of Human Gene Therapy, Departments of Medicine, Pathology and Surgery; 2and the Gene Therapy Center; 3Division of Hematology-Oncology, Department of Medicine; 4Division of Transplantation, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, United States. $    -$ /     '      

    $      1                   $  

    "   2"                            

  

                               

      $  3       '            "      G $       

     "   D $       

 "           '     3   $      

             @*'   $*'   "               -' / C   3        $      '    

         1     $

3              '   $    "       E      

           3          3       3    "'    @    -'@/   "         

       '          0   

             G               "   '@  

         - ?/ ,:"&    $69           $  0

Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy

 G

       '@""$69 ?              $       '  0

             -'@%,:/          '         "    $69       ->D('/ ?        '@%,:              

 '      $             

663. EpCAM and PSMA-T argeting of Adenoviral PSMA-Targeting Vectors to Prostate Cancer In V Vitro itro Robert Kraaij, Angélique L. C. Th. van Rijswijk, Monique H. A. Oomen, Corrina M. A. de Ridder, Chris H. Bangma. 1 Experimental Urology, Erasmus MC, Rotterdam, Netherlands. ( +( '        3   '   @   -'@/              '          '@     G

     

#         

            

    '@               "

                                          0

  

     >'#     !    (  #    '  -!(#'/                              + *) >    ) >3       '@ >'#   !(#'    

  ?'(                          "      2        

   E   

  " ?       " =,= -'   >'#/   <&58 -'   !(#'/   

  ' &"#.">?!           '                      

            >?! 3     

  ?'(     )*) >3   >'#            

!(#'       !"=6B   D*! @   "       >'#   !(#'   

 @     >'#       

 !"=                 )  

  

            

3      ?    !(#'"            

      (*)+()          ->'#/    -!(#'/                 

               

664. Loss of CAR and Integrins Binding through Point Mutations of Ad5 Capsid Karine Martin,1 Michel Perricaudet,1 Patrice Yeh,1,2 Emmanuelle Vigne.1,2 1 UMR1582, CNRS/IGR/Aventis, Villejuif, France; 2Gencell, Aventis Pharma, Vitry-sur-Seine, France.          -' /                      E         '@           

  

                           & -' &/"

            @

         1  

          

                                                      

      

           

  '@                    



    '2  -! 695 D  68;/   2"    -D 6,9/   $  -.668 D 66,/     ?  -C &9:/ '     

'         ?     

    

  @ 

  -(   ,:B78&B:";8/ '                    >8"                   ! 695D 68;'D 6,9'   '+ 

       '@    D 68;'                7   @$     

          %     " 

   -.6/       !'@% $:;      

      C    .6                   !'@" 3            '@"

          

S217